News Releases

Chronic kidney disease is a strong cardiovascular risk factor and is often accompanied by hypertension and diabetes. A new risk model for cardiovascular disease, developed by Penn, was found to be more accurate than existing clinical models.

Penn researchers identified changes in NAD metabolism in both mouse and human kidneys. The study team hopes that their research will serve as a springboard for the development of new pharmaceuticals to prevent and treat kidney disease.